HB 2136

ON APRIL 16, 2026, THE HOUSE ADOPTED AMENDMENT #2 AND PASSED HOUSE BILL 2136, AS AMENDED. AMENDMENT #2 makes the following revisions:  Removes that if a compound, mixture, or preparation is approved by the United States food and drug administration (FDA) and is designated or scheduled by the federal drug enforcement administration pursuant to federal law and is not scheduled under state law as the approved compound, mixture, or preparation, then that compound, mixture, or preparation is deemed scheduled in the same schedule that the compound, mixture, or preparation is scheduled under the federal schedules of controlled substances.  P rovide s , instead, if no objection is filed by the commissioner of mental health and substance abuse services and the commissioner of health for a substance that is approved by the FDA and designated or scheduled under federal law by a final order published in the Federal Register, then the substance is considered to be in the same schedule as such substance is designated or scheduled under the federal schedule of controlled substances after the expiration of 30 days from the date of publication of the final order. Any such designation or scheduling is effective immediately after the expiration of 30 days from the date of publication of the final order and is not contingent on the annual revision and republishing of schedules pursuant to present law.  Removes that the bill does not expand or limit a healthcare prescriber's scope of practice or authorize the prescribing of a drug product in a manner inconsistent with state or federal law.